CNPOF - Canopy Rivers Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.8019
-0.0881 (-4.66%)
At close: 3:53PM EDT
Stock chart is not supported by your current browser
Previous Close1.8900
Open1.9149
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.7700 - 1.9283
52 Week Range1.7000 - 7.3016
Volume142,197
Avg. Volume107,646
Market Cap334.737M
Beta (3Y Monthly)N/A
PE Ratio (TTM)6.93
EPS (TTM)0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies
    CNW Group

    Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies

    TORONTO , Aug.15, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio companies, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF) and TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), have entered into a purchase and supply agreement, demonstrating the type of collaboration and synergy seen throughout the Canopy Rivers ecosystem. As part of the agreement, JWC will supply cannabis flower and oils to TerrAscend, which will be made available for purchase on TerrAscend's online medical sales platform, Solace Health, providing JWC with exposure to thousands of registered medical patients across Canada .

  • PR Newswire

    Canopy Rivers to Report First Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

    TORONTO, Aug. 13, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) will report its first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. The Company's unaudited condensed interim financial statements and Management's Discussion and Analysis for the three months ended June 30, 2019 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/investors/financials-and-public-filings. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (WEED.TO) (CGC), which are currently scheduled to be released on August 14, 2019.

  • PR Newswire

    Canopy Rivers receives conditional approval to graduate to the Toronto Stock Exchange

    TORONTO, Aug. 12, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its class A subordinated voting shares (the "Subordinated Voting Shares") on the TSX.

  • Benzinga

    TerrAscend Acquires Ilera In Deal Valued Upwards Of $125M

    Canada-based TerrAscend Corp (OTC:TRSSF) (CSE:TER), the first licensed for sales in Canada, the U.S. and the E.U., announced this week it's acquiring Ilera Healthcare, one of the five vertically-integrated cannabis cultivators, processors and dispensary operators in Pennsylvania. Subject to regulatory approval, the company will buy Ilera for total consideration of $125 million to $225 million, which will be paid in a combination of cash and TerrAscend shares. TerrAscend is a portfolio company of Canopy Rivers Inc (OTC: CNPOF), the investment arm of Canopy Growth Corp (NYSE: CGC).

  • PR Newswire

    Canopy Rivers Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta

    TORONTO, Aug. 8, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company, YSS Corp. ("YSS") (TSXV:YSS) (WKN:A2PMAX), on receiving its 12th cannabis retail licence from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Operating under the YSS™ brand name, the newly licensed store is strategically located in a high-traffic suburban area in northwest Edmonton. YSS has six operational stores located in Calgary and Red Deer, with an additional two licensed locations expected to open in Vermilion and Vegreville within the next week.

  • Canopy Rivers Portfolio Company Terrascend Announces Acquisition of Vertically-Integrated Pennsylvania Cannabis Operator
    CNW Group

    Canopy Rivers Portfolio Company Terrascend Announces Acquisition of Vertically-Integrated Pennsylvania Cannabis Operator

    TORONTO , Aug. 6, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), has signed a definitive agreement to acquire Ilera Healthcare ("Ilera"), a vertically-integrated cannabis cultivator, processor, and dispensary operator in Pennsylvania . Ilera's state-of-the-art, fully integrated seed-to-sale operations adds to TerrAscend's growing global footprint, currently spanning multiple U.S. states, Canada and the European Union. "TerrAscend's rapid expansion in the U.S. has been driven by strategic, accretive acquisitions of quality operators with strong track records of success," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Benzinga

    Highlights From LeafLink's Q2 Cannabis Wholesale Report, Hits $1B In Orders

    Last month, the wholesale cannabis management platform LeafLink has published its second-quarter update. LeafLink said its platform has seen a tremendous growth in orders: they've reached $1 billion and cover 20 territories in Canada and the U.S.

  • PR Newswire

    Canopy Rivers Announces Health Canada Approval for Significant Expansion to the Licensed Infrastructure at Radicle

    TORONTO, Aug. 1, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce that its portfolio company Radicle Medical Marijuana Inc. ("Radicle") has received approval from Health Canada for its production facility expansion project. This approval effectively doubles Radicle's production footprint, significantly increasing its capacity to 6,000 kilograms per year. "We are thrilled with the continued growth happening at Radicle," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada
    CNW Group

    Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada

    TORONTO , July 22, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce that its 49%-owned joint venture, PharmHouse Inc.  ("PharmHouse"), has received a cultivation licence from Health Canada. PharmHouse will be immediately commencing operations in 190,000 sq. ft. of licensed nursery infrastructure and plans to ramp up the entire 1.3 million sq. ft. ultramodern greenhouse before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products to the Canopy Rivers ecosystem of partners, both domestically and internationally. "This is a significant corporate milestone for Canopy Rivers.

  • Benzinga

    Canopy Rivers Reports Q4 Earnings

    A venture capital investment company that seeks opportunities in the cannabis industry, Canopy Rivers (TSXV: RIV) (OTC: CNPOF ) released its financial report for the fourth quarter and fiscal year on Tuesday. ...

  • PR Newswire

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update

    TORONTO, July 16, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (RIV.V) (CNPOF) today released its financial results for the three and twelve months ended March 31, 2019. The Company's audited consolidated financial statements for the twelve months ended March 31, 2019, and its full Management's Discussion and Analysis (the "MD&A") for the three and twelve months ended March 31, 2019, are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/financials. "It was a year full of milestones and significant achievements for Canopy Rivers," said Narbe Alexandrian, President and Chief Executive Officer of Canopy Rivers.

  • Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta
    CNW Group

    Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta

    TORONTO , July 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company, YSS Corp. ("YSS") (TSXV:YSS) (WKN:A2PMAX), on receiving five cannabis retail licences from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Canopy Rivers currently holds approximately 8% of the issued and outstanding common shares in the capital of YSS on a fully-diluted basis.

  • Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada
    CNW Group

    Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario .

  • Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada
    CNW Group

    Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF) on its announcement today that it has received an amendment to its licence from Health Canada allowing for the sale of cannabis oils from its facility in Mississauga, Ontario . This news comes two months following TerrAscend's announcement that it had been issued a Good Manufacturing Practice (GMP) certificate in accordance with the rules governing medical products in the European Union, in conjunction with establishing a sales and distribution agreement with iuvo Therapeutics GmbH, a German pharmaceutical wholesaler. "With another key milestone achieved by TerrAscend in a matter of a few short months, the company continues to demonstrate its ambition to become a global provider of pharmaceutical-grade cannabis products," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • CNW Group

    Canopy Rivers Announces Change to Board of Directors

    Canopy Rivers Announces Change to Board of Directors